A detailed history of Jacobs & CO transactions in Baxter International Inc stock. As of the latest transaction made, Jacobs & CO holds 7,829 shares of BAX stock, worth $227,667. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,829
Previous 9,254 15.4%
Holding current value
$227,667
Previous $309,000 3.88%
% of portfolio
0.03%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 01, 2024

SELL
$32.85 - $40.26 $46,811 - $57,370
-1,425 Reduced 15.4%
7,829 $297,000
Q2 2024

Jul 12, 2024

SELL
$32.87 - $43.55 $64,589 - $85,575
-1,965 Reduced 17.51%
9,254 $309,000
Q4 2023

Jan 17, 2024

SELL
$31.71 - $38.95 $203,324 - $249,747
-6,412 Reduced 36.37%
11,219 $433,000
Q3 2023

Oct 13, 2023

SELL
$37.32 - $49.29 $68,556 - $90,545
-1,837 Reduced 9.44%
17,631 $665,000
Q2 2023

Jul 11, 2023

SELL
$39.98 - $47.68 $1.13 Million - $1.35 Million
-28,369 Reduced 59.3%
19,468 $886,000
Q1 2023

Apr 17, 2023

SELL
$37.58 - $52.57 $169,861 - $237,616
-4,520 Reduced 8.63%
47,837 $1.94 Million
Q4 2022

Jan 13, 2023

BUY
$49.7 - $57.71 $112,819 - $131,001
2,270 Added 4.53%
52,357 $2.67 Million
Q3 2022

Oct 11, 2022

BUY
$53.86 - $66.8 $85,637 - $106,212
1,590 Added 3.28%
50,087 $2.7 Million
Q2 2022

Jul 19, 2022

BUY
$63.83 - $80.0 $90,319 - $113,200
1,415 Added 3.01%
48,497 $3.11 Million
Q1 2022

Apr 14, 2022

SELL
$76.85 - $89.45 $47,493 - $55,280
-618 Reduced 1.3%
47,082 $3.65 Million
Q4 2021

Jan 21, 2022

SELL
$74.57 - $87.19 $42,877 - $50,134
-575 Reduced 1.19%
47,700 $4.09 Million
Q3 2021

Oct 13, 2021

BUY
$73.77 - $83.61 $247,277 - $280,260
3,352 Added 7.46%
48,275 $3.88 Million
Q2 2021

Jul 15, 2021

SELL
$80.5 - $88.01 $13,604 - $14,873
-169 Reduced 0.37%
44,923 $3.62 Million
Q1 2021

Apr 05, 2021

BUY
$76.38 - $86.03 $763 - $860
10 Added 0.02%
45,092 $3.8 Million
Q4 2020

Jan 12, 2021

BUY
$75.39 - $82.36 $185,308 - $202,440
2,458 Added 5.77%
45,082 $3.62 Million
Q3 2020

Dec 03, 2020

BUY
$78.33 - $90.73 $58,120 - $67,321
742 Added 1.77%
42,624 $3.43 Million
Q2 2020

Jul 09, 2020

SELL
$78.66 - $94.14 $92,346 - $110,520
-1,174 Reduced 2.73%
41,882 $3.61 Million
Q1 2020

Apr 13, 2020

SELL
$71.57 - $93.3 $51,172 - $66,709
-715 Reduced 1.63%
43,056 $3.5 Million
Q4 2019

Jan 29, 2020

BUY
$76.7 - $88.45 $157,235 - $181,322
2,050 Added 4.91%
43,771 $3.66 Million
Q3 2019

Nov 04, 2019

SELL
$81.4 - $89.78 $26,455 - $29,178
-325 Reduced 0.77%
41,721 $3.65 Million
Q2 2019

Aug 01, 2019

BUY
$73.44 - $82.41 $56,181 - $63,043
765 Added 1.85%
42,046 $3.44 Million
Q1 2019

Apr 29, 2019

SELL
$64.48 - $81.31 $96,397 - $121,558
-1,495 Reduced 3.49%
41,281 $3.36 Million
Q4 2018

Feb 07, 2019

BUY
$61.45 - $77.8 $21,507 - $27,230
350 Added 0.82%
42,776 $2.82 Million
Q3 2018

Oct 23, 2018

SELL
$70.71 - $77.75 $31,819 - $34,987
-450 Reduced 1.05%
42,426 $3.27 Million
Q2 2018

Jul 19, 2018

SELL
$63.43 - $75.41 $38,058 - $45,246
-600 Reduced 1.38%
42,876 $3.17 Million
Q1 2018

Apr 30, 2018

SELL
$62.56 - $72.26 $24,085 - $27,820
-385 Reduced 0.88%
43,476 $2.83 Million
Q4 2017

Feb 09, 2018

SELL
$61.45 - $66.05 $58,930 - $63,341
-959 Reduced 2.14%
43,861 $2.84 Million
Q3 2017

Nov 14, 2017

BUY
$59.5 - $64.61 $2.67 Million - $2.9 Million
44,820
44,820 $2.81 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Jacobs & CO Portfolio

Follow Jacobs & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs & CO with notifications on news.